Prehliadač alebo jeho nastavenia nie sú podporované.

Praktik.ai používa moderné webové technológie kvôli bezpečnosti, rýchlosti a spoľahlivému prihlasovaniu. Tento prehliadač ich nepodporuje alebo blokuje JavaScript, preto sa aplikácia nemusí správne načítať.

Aktualizujte prosím Chrome, Edge, Firefox alebo Safari na najnovšiu verziu a stránku potom obnovte.

Ak používate Windows 7, Windows 8 alebo Windows 8.1, Chrome a Edge už nemusia ponúkať novú verziu. V takom prípade použite novšie zariadenie alebo kontaktujte podporu Praktik.ai.

Prohlížeč nebo jeho nastavení nejsou podporované.

Praktik.ai používá moderní webové technologie kvůli bezpečnosti, rychlosti a spolehlivému přihlašování. Tento prohlížeč je nepodporuje nebo blokuje JavaScript, proto se aplikace nemusí správně načíst.

Aktualizujte prosím Chrome, Edge, Firefox nebo Safari na nejnovější verzi a stránku potom obnovte.

Pokud používáte Windows 7, Windows 8 nebo Windows 8.1, Chrome a Edge už nemusí nabízet novou verzi. V takovém případě použijte novější zařízení nebo kontaktujte podporu Praktik.ai.

Your browser or its settings are not supported.

Praktik.ai uses modern web technologies for security, speed, and reliable sign-in. This browser does not support them, or JavaScript is blocked, so the app may not load correctly.

Please update Chrome, Edge, Firefox, or Safari to the latest version and then reload this page.

If you use Windows 7, Windows 8, or Windows 8.1, Chrome and Edge may no longer offer a newer version. In that case, use a newer device or contact Praktik.ai support.

Not effective COMMISSION DECISION of 18 October 2007 on the renewal of the Community stocks of live attenuated vaccine against classical swine fever (notified under document number C(2007) 4699) (2007/682/EC)

Rozhodnutie č. 682/2007

Text language

Important dates

Declared: 18. októbra 2007
Approved: 18. októbra 2007
Effective from: 18. októbra 2007
Effective until: 13. júla 2021

Documents and links

COMMISSION DECISION

of 18 October 2007

on the renewal of the Community stocks of live attenuated vaccine against classical swine fever

(notified under document number C(2007) 4699)

(2007/682/EC)

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European Community,

Having regard to Council Decision 90/424/EEC of 26 June 1990 on expenditure in the veterinary field (1), and in particular Article 6(2) and Article 8(2) thereof,

Having regard to Council Directive 2001/89/EC of 23 October 2001 on Community measures for the control of classical swine fever (2), and in particular Article 18(2) thereof,

Whereas:

(1)

Classical swine fever is a threat for domestic and feral pigs (wild boar) in the Community.

(2)

Outbreaks of classical swine fever in domestic pig holdings can lead to serious consequences and economic losses in the Community, in particular if they occur in areas with a high density of pigs.

(3)

The rules for applying emergency vaccination of domestic and feral pigs are laid down in Directive 2001/89/EC.

(4)

The Community has purchased 1 000 000 doses of live attenuated classical swine fever vaccine and made arrangements for keeping it in stock and making it rapidly available in case of an emergency vaccination of domestic pigs.

(5)

Those doses have been made available to Romania in July 2007. Accordingly, they need to be replaced for the purpose of maintaining the Community’s capability to respond quickly to the need to carry out emergency vaccination against classical swine fever.

(6)

In addition, in the light of the overall disease situation in certain Member States the stock of live attenuated vaccine should be replaced quickly when depleted in order to maintain the Community’s capability to respond to an emergency.

(7)

The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on the Food Chain and Animal Health,

HAS ADOPTED THIS DECISION:

Article 1

1.   The Community shall purchase as soon as possible 1 000 000 doses of live attenuated classical swine fever vaccine.

2.   The Community shall make arrangements for the storage and distribution of the vaccine referred to in paragraph 1.

Article 2

If the stock of vaccine referred to in Article 1(1) becomes depleted, it may be replaced by 1 000 000 doses up to four times during a period of five years after the date of the first purchase.

Article 3

The maximum cost of the measures referred to in Articles 1 and 2 shall not exceed EUR 1 500 000.

Article 4

The measures provided for in Article 1(2) shall be carried out by the Commission in cooperation with the suppliers designated by call for tender.

Article 5

This Decision is addressed to the Member States.

Done at Brussels, 18 October 2007.

For the Commission

Markos KYPRIANOU

Member of the Commission

Poznámky

(1)   OJ L 224, 18.8.1990, p. 19. Decision as last amended by Regulation 1791/2006 (OJ L 363, 20.12.2006, p. 1).

(2)   OJ L 316, 1.12.2001, p. 5. Directive as last amended by Directive 2006/104/EC (OJ L 363, 20.12.2006, p. 352).